Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo

Prostate

Volumn 51, Issue 2, 2002, Pages 141-152

  Devi, Gayathri R ^a,b   Sprenger, Cynthia C ^c   Plymate, Stephen R ^c   Rosenfeld, Ron G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b AVI BIOPHARMA INC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Insulin like growth factor; M12 prostate epithelial cells; Tumor suppressor

Indexed keywords

COMPLEMENTARY DNA; NEURON SPECIFIC ENOLASE; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DENSITY; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN SECRETION;

APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA; DNA, COMPLEMENTARY; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036571289     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10068     Document Type: Article

References (50)

1. Cancer statistics
2. Carcinoma of the prostate
3. The IGF axis in the prostate
4. The insulin-like growth factor system in the prostate
5. Plasma Igf-I and prostate cancer risk: A prospective study
6. Igf-I prostate cancer risk: A population-based, case control study
7. Insulin-like growth factors and prostate cancer: A population-based case-control study in china
8. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
9. Insulin-like growth factors and their binding proteins: Biological actions
10. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate
11. Inverse relation between prostate-specific antigen and IGFBP-3 in bone metastases and serum of patients with prostate cancer
12. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
13. Prostate specific antigen is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma
14. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling
15. Effect of IGFBP-3 on IGF-and IGF-analog-induced insulin-like growth factor-I receptor signaling
16. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
17. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism
18. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
19. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
20. Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation
21. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein-3 expression in cultured porcine sertoli cells
22. Estradiol and anti-estrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
23. Induction of the growth inhibitor IGF binding protein 3 by p53
24. Cellular actions of insulin-like growth factor binding proteins
25. Insulin-like growth factor binding protein-3 mediates 1alpha,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1
26. Growth factors as mediators of androgen action during the development of the male urogenital tract
27. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid
28. Metastatic sublines of an SV40T antigen immortalized human prostate epithelial cell line
29. Cytogenetic characterization of the human prostate cancer cell lines P69SV40T and its novel tumorigenic sublines M2182 and M15
30. Tumorigenecity of SV40T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor expression
31. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer
32. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid
33. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
34. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
35. Mitochondria and apoptosis
36. Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: Clinical correlations
37. The effect of IGF system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen
38. Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: A model for the cellular functions of IGFBPs
39. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation
40. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media
41. Interaction of IGFBP-related protein-1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells
42. Acquisition of neuroendocrine chracteristics by prostate tumor cells is reversible: Implications for prostate cancer progression
43. Neuroendocrine differentiation of prostatic carcinoma
44. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells
45. Insulin-like growth factor binding protein (IGFBP-3) and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
46. p53 and IGFBP-3: Apoptosis and cancer protection
47. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells
48. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation
49. Programmed cell death (apoptosis) and cancer chemotherapy
50. Target to apoptosis: A hopeful weapon for prostate cancer